Good Sleep Co is proud to share a major milestone in our mission to make better sleep accessible to everyone. Our OTC oral appliance, Hushd Avera™, has officially received FDA 510(k) clearance (K252161) for the treatment of snoring in adults.
This clearance marks the start of an exciting new chapter for both patients and clinicians to bridge the gap between over-the-counter solutions and long-term, custom oral-appliance therapy.
A Temporary + OTC Solution That Fits Naturally Into Clinical Care
Hushd Avera™ has been purpose-built as a temporary, boil-and-bite mandibular advancement device (MAD). Its role is simple but critical: to provide a safe, comfortable, clinically validated interim option while patients move toward a custom-fabricated device.
For practitioners, Hushd Avera is ideal for:
- Trialing oral-appliance therapy before prescribing a custom device
- Evaluating treatment efficacy in a low-barrier, patient-friendly way
- Maintaining therapy during restorative or cosmetic dental work
- Filling the waiting period while a custom Hushd Pro is being manufactured
- Guiding self-directed patients away from low-quality OTC products and into clinical care
Because Avera is intentionally designed as TEMP + OTC, clinicians can confidently use it without worrying about competing with or replacing their custom appliance offerings.
A Clinically Significant Bridge in the Patient Journey
For many people, the path to treating sleep apnea doesn’t start in a clinic. It starts online with people searching for solutions to snoring or poor sleep. Hushd Avera meets patients exactly where they are and helps usher them into proper, medically guided therapy.
As Good Sleep Co Co-CEO Joel Simpson explains:
“Hushd Avera fills a critical gap in the patient pathway. Clinicians can now test efficacy, titrate mandibular advancement, and keep patients treated while waiting for their custom Hushd Pro device, all without compromising comfort or care continuity.”
“What’s equally powerful,” he adds, “is how Avera allows us to meet patients where they are, often online exploring snoring solutions and redirect them into a continuum of professionally managed OSA care.”
In other words, Avera acts as both a bridge and a compass improving care continuity while making it easier for patients to commit to long-term custom therapy.
Engineering Simplicity Into a Trial-Ready Device
Designing a two-piece boil-and-bite device that performs like a clinical-grade oral appliance is no easy task. Hushd Avera™ represents years of research, prototyping, and real-world validation.
The engineering team combined:
- Advanced CAD modelling
- Materials-science refinement
- Thermal-forming innovation
- Iterative clinical feedback
The result is a device that is adjustable, stable, comfortable, and easy for patients to fit on their own unlocking reliable trial therapy and better patient onboarding.
Part of a Connected Sleep Care Ecosystem
Avera integrates seamlessly into Good Sleep Co’s broader connected system:
- Hushd Pro custom MAD lineup
- Hushd Sense at-home AI-enabled sleep monitoring
- Resdent clinical workflow software
Clinicians can document trial outcomes, track case progress, evaluate residual symptoms, and transition patients into custom therapy all within a unified experience.
This ecosystem is designed to close the loop across screening, diagnosis, treatment, and follow-up, enabling more efficient, more modern sleep-health care.
A New Era for Accessible OSA Therapy
The FDA clearance of Hushd Avera™ marks an important step toward expanding access to effective, patient-friendly snoring solutions.
It strengthens the pathway from OTC exploration to custom clinical care, supports clinicians in providing continuity of treatment, and empowers patients to experience the benefits of oral-appliance therapy sooner.
For both patients and practitioners, Avera opens the door to a more connected, more flexible, and more accessible sleep care experience.